Editorial: Peptidases as a therapeutic target in anti-cancer management.

This document is an editorial published in Frontiers in Pharmacology titled "Peptidases as a therapeutic target in anti-cancer management." The editorial discusses the potential of peptidases, a family of proteolytic enzymes, as targets for cancer treatment. Peptidases play important roles in various biological processes and their dysregulation is associated with cancer progression. The editorial highlights different peptidase families and their mechanisms of action, as well as recent studies on the development of peptidase inhibitors and their potential to improve cancer treatment. The authors emphasize the need for further research in this field to better understand the role of peptidases in cancer progression and develop new therapeutic approaches. [Extracted from the article]